[1]
2017. The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma. Biomolecules and Biomedicine. 17, 2 (May 2017), 138–143. DOI:https://doi.org/10.17305/bjbms.2017.1684.